Logo

Similar Products

Description

Since 1971, we have established ourselves as a trusted supplier of high-quality Isoniazid (INH) bulk active pharmaceutical ingredient to the global pharmaceutical industry. Our FDA...
Since 1971, we have established ourselves as a trusted supplier of high-quality Isoniazid (INH) bulk active pharmaceutical ingredient to the global pharmaceutical industry. Our FDA-approved manufacturing facilities ensure reliable supply of IP, BP, EP, USP, and injectable grades maintained in ready stock for immediate shipment. We specialize in providing specification-compliant Isoniazid that meets rigorous quality standards for anti-tuberculosis medications, supported by comprehensive documentation and regulatory compliance expertise. Our commitment to quality assurance and customer satisfaction makes us the preferred partner for pharmaceutical companies requiring consistent, high-purity API for critical healthcare applications.

This essential API serves pharmaceutical manufacturers producing tuberculosis treatment regimens for both public health programs and private healthcare markets. It is fundamental for companies developing fixed-dose combinations, hospital injectables, and preventive therapy medications that comply with international therapeutic standards. The pharmaceutical industry relies on consistent quality Isoniazid for manufacturing WHO-recommended TB drugs supplied to national tuberculosis programs worldwide. Manufacturers serving generic pharmaceutical markets, government health suppliers, and international healthcare organizations depend on our API for producing life-saving medications that effectively combat tuberculosis across diverse patient populations.

Our business value stems from five decades of reliable API supply supported by uncompromising quality control systems. We differentiate through batch-to-batch consistency, regulatory compliance across multiple pharmacopeial standards, and flexible supply chain solutions that ensure manufacturing continuity. Pharmaceutical partners benefit from our extensive experience in global exports, comprehensive documentation support, and technical assistance that streamline production processes. We deliver more than product – we provide partnership reliability that ensures uninterrupted manufacturing operations and maintained therapeutic efficacy for patients depending on tuberculosis treatment medications worldwide.

Key Features:
- Compliant with multiple pharmacopeial standards including IP, BP, EP, and USP
- Available in injectable grade suitable for sterile formulation manufacturing
- Sourced from FDA-approved manufacturing facilities ensuring regulatory compliance
- Ready stock availability enables immediate shipment and production planning
- Consistent batch-to-batch quality verified through rigorous testing protocols

Benefits:
- Ensures regulatory compliance for pharmaceutical manufacturers across global markets
- Supports sterile manufacturing processes with injectable grade availability
- Reduces supply chain risks through ready stock and reliable delivery schedules
- Maintains therapeutic efficacy through consistent high-purity API quality
- Provides manufacturing continuity with batch-to-batch consistency and reliability

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Isoniazid bulk API serves as a critical first-line antituberculosis active pharmaceutical ingredient for manufacturers producing TB treatment medications. This high-purity compound is formulated into tablets, capsules, and injectable forms that meet global pharmacopeial standards for therapeutic efficacy and patient safety in tuberculosis care programs worldwide.

Pharmaceutical companies rely on this API for manufacturing WHO-recommended TB regimens and combination therapies. The material supports production of both drug-sensitive tuberculosis treatments and preventive therapy medications, ensuring consistent quality across finished dosage forms for hospital use, clinical applications, and public health programs targeting tuberculosis elimination.
- Core active ingredient in fixed-dose combination tablets for first-line tuberculosis treatment regimens
- Essential component in injectable formulations manufactured for hospital and clinical administration
- Raw material for preventive therapy medications targeting latent tuberculosis infection treatment
- Bulk API supply for pharmaceutical companies producing WHO-recommended TB drug combinations
- Active pharmaceutical ingredient for government health programs and national tuberculosis control initiatives

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
Verified
IndiaMaharashtra, India
Distributor / WholesalerImporter / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Trusted Isoniazid INH Bulk API Supplier FDA Approved IP BP EP USP

Trusted Isoniazid INH bulk API supplier since 1971 offers FDA-approved IP BP EP USP injectable grades for pharmaceutical manufacturers requiring reliable tuberculosis treatment medications with consistent quality.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
Verified
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier

No supplier products found.

Related Products